The magazine, owned by the Massachusetts Institute of Technology, highlighted the work of electronics engineer Sergio Marín as one of the 2020 innovators in Latin America.

"Netux has built a unique platform in which it combines hardware, software and artificial intelligence devices to make the day-to-day running of healthcare systems much more efficient. Thus Sergio Marín seeks to reduce healthcare spending due to inefficiencies.". With these words the MIT Technology Review, owned by the Massachusetts Institute of Technology (MIT), recognizes the innovative work of this engineer and CEO of the Colombian start-up Netux, a SENA-branded venture.

This is an initiative that, in 2010, received seed capital resources from the Entity to support the development of solutions for the health sector, based on the Internet of Things (IoT).

When he was awarded the Emprender Fund, with his partner Juan Velásquez, Sergio was 24 years old and they were just beginning the initial stage of their venture. Ten years later, they are developing advanced processes with sensors connected to the internet and software in the cloud, which make the operation of the country's health sector entities more efficient, safe and economical. Their technology is able to monitor patients in real time and remotely, also improving access to healthcare systems around the world.

"We were supported by the Fondo Emprender del SENA in 2010, and although we were not legally constituted, it was very valuable and allowed us to understand the steps to land the business model. We received $43 million, which gave us a very important push to materialize our dreams," recalls Marín.recalls Marín.

"Fondo Emprender played and plays a very important role. In fact, they have always been there, with accompaniment processes, we still talk to our mentor. We love SENA very much", adds the entrepreneur.adds the entrepreneur.

Netux provides its services to clinics, hospitals, pharmacies and medical laboratories, which with its technology can expand coverage and capacity of care without the need for additional infrastructure. In addition, they can avoid losses of medical supplies thanks to 7/24 real-time monitoring of the cold chain of vaccines, blood banks and medicines. It also works with insurance companies (EPS) and in the public health dimension of the Government.

‍

Read the full article here